University Hospital Tübingen, Center for Neurology
Tübingen, 72076, Germany
NCT Number: NCT03104088
Comparing the cognitive levels of patients with SPG4 mutations to healthy controls.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Observational
Tübingen, 72076, Germany
Comparing the cognitive levels of patients with SPG4 mutations to healthy controls by using the CANTAB® and MoCA.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
CANTAB Cognitive Assessment (tablet based cognitive testing from CAMCOG)
Montreal cognitive assessment (MOCA) in German
Time frame: day 1
Number of SPG4 patients with affections in the examined cognitive domains by using CANTAB
Looking for future studies?
Notify MeUniversity Hospital Tuebingen
Other
Studying Cognition in SPG4 Compared to Healthy Controls
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05367076
Behavior, Cognition Disorders
Toronto, Ontario, Canada
View Trial DetailsNCT07825909
Cognition Disorders, Cognitive Dysfunction
Padova, Padova/Veneto, Italy
View Trial DetailsNCT05333549
Basal Ganglia Diseases, Brain Diseases
Richmond, Virginia, United States
View Trial DetailsNCT07831850
Cognition Disorders, Cognitive Dysfunction
Roquetas de Mar, Almería, Spain
View Trial Details